Abbott Laboratories
NYSE:ABT

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist
Price: 132.82 USD 1.48% Market Closed
Market Cap: 230.4B USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one ABT stock under the Base Case scenario is 129.82 USD. Compared to the current market price of 132.82 USD, Abbott Laboratories is Overvalued by 2%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ABT Relative Value
Base Case
129.82 USD
Overvaluation 2%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

5.4
P/S
P/S
Price to Sales
5.4
vs History
15
vs Industry
25
Median 3Y
4.5
Median 5Y
4.7
Industry
2.2
Forward
5.1
More Details
17
P/E
P/E
Price to Earnings
17
vs History
93
vs Industry
31
Median 3Y
29.9
Median 5Y
32
Industry
21.9
Forward
25.5
More Details
26.9
P/OCF
P/OCF
Price to OCF
26.9
vs History
15
vs Industry
14
Median 3Y
23.6
Median 5Y
22.9
Industry
13.5
More Details
48.9
P/FCFE
P/FCFE
Price to FCFE
48.9
vs History
26
vs Industry
9
Median 3Y
36.6
Median 5Y
34.8
Industry
19.3
More Details
4.8
P/B
P/B
Price to Book Value
4.8
vs History
74
vs Industry
17
Median 3Y
4.9
Median 5Y
5
Industry
2.1
More Details
5.5
EV/S
EV/S
Enterprise Value to Sales
5.5
vs History
22
vs Industry
23
Median 3Y
4.6
Median 5Y
4.9
Industry
2.3
Forward
5.2
More Details
9.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
9.9
vs History
20
vs Industry
22
Median 3Y
8.4
Median 5Y
8.7
Industry
4.8
More Details
22.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
22.1
vs History
19
vs Industry
15
Median 3Y
19
Median 5Y
19.6
Industry
11.5
Forward
19.6
More Details
31.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
31.7
vs History
22
vs Industry
13
Median 3Y
28.6
Median 5Y
28.8
Industry
15.6
Forward
22.5
More Details
27.4
EV/OCF
EV/OCF
Enterprise Value to OCF
27.4
vs History
20
vs Industry
14
Median 3Y
24.2
Median 5Y
24.2
Industry
13.3
More Details
36.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
36.9
vs History
30
vs Industry
13
Median 3Y
32.5
Median 5Y
32.5
Industry
17.3
More Details
3.4
EV/IC
EV/IC
Enterprise Value to IC
3.4
vs History
30
vs Industry
25
Median 3Y
3.2
Median 5Y
3.2
Industry
1.8
More Details

Multiples Across Competitors

ABT Competitors Multiples
Abbott Laboratories Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Abbott Laboratories
NYSE:ABT
230B USD 5.4 17 22.1 31.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.6B USD 21.6 76.2 60.8 73.1
US
Boston Scientific Corp
NYSE:BSX
154.7B USD 8.8 76.1 35.9 49.7
US
Stryker Corp
NYSE:SYK
144.3B USD 6.4 48.2 24.9 30.1
IE
Medtronic PLC
NYSE:MDT
108.9B USD 3.3 25.6 13.7 19.3
DE
Siemens Healthineers AG
XETRA:SHL
53.7B EUR 2.4 27.1 15.6 22.2
US
Becton Dickinson and Co
NYSE:BDX
48.9B USD 2.4 28 12.5 22.5
US
Edwards Lifesciences Corp
NYSE:EW
44.5B USD 8 10.7 24.4 26.8
US
IDEXX Laboratories Inc
NASDAQ:IDXX
38.5B USD 9.9 43.4 30.8 34.4
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
266.3B CNY 7.5 23.9 20.9 20.9
US
Resmed Inc
NYSE:RMD
35.2B USD 7 26.8 19.1 21.7

See Also

Summary
ABT intrinsic value, competitors valuation, and company profile.
DCF Valuation
ABT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ABT stock valuation using valuation multiples.
Wall Street Estimates
ABT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ABT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 251,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.